相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
Hisham Mehanna et al.
LANCET (2019)
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
Maura L. Gillison et al.
LANCET (2019)
Outcomes Between Concurrent Cisplatin Versus Carboplatin-Based Chemotherapy in Locally Advanced Oropharyngeal Carcinoma: A SEER-Medicare Analysis
A. Amini et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
The role of p16 as a biomarker in nonoropharyngeal head and neck cancer
Lucas K. Vitzthum et al.
Oncotarget (2018)
Trends in chemoradiation use in elderly patients with head and neck cancer: Changing treatment patterns with cetuximab
Shrujal S. Baxi et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck
Nadeem Riaz et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2016)
Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies
Gwo Yaw Ho et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab
David I. Rosenthal et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial
Stefano Maria Magrini et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Concurrent chemoradiotherapy with cisplatin or cetuximab for locally advanced head and neck squamous cell carcinomas: Does human papilloma virus play a role?
Dan Ou et al.
ORAL ONCOLOGY (2016)
A meta-analysis comparing cisplatin-based to carboplatin-based chemotherapy in moderate to advanced squamous cell carcinoma of head and neck (SCCHN)
Jian Guan et al.
ONCOTARGET (2016)
Comparison of every 3 week cisplatin or weekly cetuximab with concurrent radiotherapy for locally advanced head and neck cancer
Tobin J. Strom et al.
ORAL ONCOLOGY (2015)
Efficacy of concurrent cetuximab vs. 5-fluorouracil/carboplatin or high-dose cisplatin with intensity-modulated radiation therapy (IMRT) for locally-advanced head and neck cancer (LAHNSCC)
Lauren Q. Shapiro et al.
ORAL ONCOLOGY (2014)
Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck
Jay S. Cooper et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN) Analysis of Chemoradiation Treatment Approaches in the United States
Stuart J. Wong et al.
CANCER (2011)
CONCURRENT CISPLATIN AND RADIATION VERSUS CETUXIMAB AND RADIATION FOR LOCALLY ADVANCED HEAD-AND-NECK CANCER
Lawrence Koutcher et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
James A. Bonner et al.
LANCET ONCOLOGY (2010)
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
K. Kian Ang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
Jean-Pierre Pignon et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation
Nuran Senel Bese et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
JA Bonner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck
JS Cooper et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)